期刊文献+

cT1N0M0肺腺癌肺内叶段淋巴结转移规律对病人手术方式选择的影响 被引量:1

下载PDF
导出
摘要 目的:探究cT1N0M0肺腺癌病人的肺内叶段淋巴结转移规律及其对手术方式选择的影响。方法:对95例cT1N0M0肺腺癌病人进行肺内叶段淋巴结再分检,并对病人的肺叶切片和其他各站淋巴结进行病理检查。结合病人的临床资料,展开统计分析,确定治疗方案。结果:PN1分期病人共有11例,其中有10例(90.91%)病人存在12~14组淋巴结节转移,3例(27.27%)病人有12~14组肺叶内段淋巴结;PN2病人共5例,1例病人仅存在12~14组肺内叶段淋巴结转移,4例病人同时存在N1、N2站淋巴结转移,3例为12~14组淋巴结转移,1例为13组和7组淋巴结转移。4例病人病人发生误诊诊断为PN0,表明N分期假阴性率为5.06%(4/79),N1站淋巴结节转移漏诊率为33.33%(5/15)。病人的影像学表现为单纯GNN,发生无法清扫或是不易解剖到肺内叶段淋巴结节转移的概率较低。结论:肺内叶段淋巴结分检能够提高病人肿瘤分期的准确性,为临床诊断和治疗方案的确定提供更加科学、准确的依据,改善病人的预后。
出处 《蚌埠医学院学报》 CAS 2019年第10期1373-1376,共4页 Journal of Bengbu Medical College
  • 相关文献

参考文献10

二级参考文献81

  • 1Watanabe S, Oda M, Tsunezuka Y, et al. Peripheral small-sized (2 cm or less) non-small cell lung cancer with mediastinal lymph node metastasis:clinicopathologic features and patterns of nodal spread.Eur J Cardiothorac Surg,2002,22(6) : 995-999.
  • 2Watanabe S, Oda M, Go T, et al. Should mediastinal nodal dissection be routinely undertaken in patients with peripheral small-sized(2 cm or less) lung cancer? Retrospective analysis of 225 patients.Eur J Cardiothorac Surg,2001,20(5):1007-1011.
  • 3Takizawa T, Terashima M, Koike T, et al. Lymph node metastasis in small peripheral adenocarcinoma of the lung. J Thorac Cardiovasc Surg,1998,116(2) : 276-280.
  • 4Takamochi K, Nagai K, Suzuki K, et al. Clinical predictors of N2 disease in non-small cell lung cancer. Chest,2000,117(6) : 1577-1582.
  • 5Suzuki K. Nagai K, Yoshida J, et al. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg, 1999,117(3) :593-598.
  • 6Jemal A,Bray F,Center MM. Global cancer statistics[J].{H}CA-A Cancer Journal for Clinicians,2011,(2):69-90.
  • 7Schiller JH,Harrington D,Belani CP. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer[J].{H}New England Journal of Medicine,2002,(2):92-98.
  • 8Soda M,Choi YL,Enomoto M. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer[J].{H}NATURE,2007,(7153):561-566.
  • 9Rikova K,Guo A,Zeng Q. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer[J].{H}CELL,2007,(6):1190-1203.
  • 10Christensen JG,Zou HY,Arango ME. Cytoreductive antitumor activity of PF-2341066,a novel inhibitor of anaplastic lymphoma kinase and c-Met,in experimental models of anaplastic large-cell lymphoma[J].{H}Molecular Cancer Therapautics,2007,(12 Pt 1):3314-3322.

共引文献128

同被引文献11

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部